A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes. (Q51305662)
Jump to navigation
Jump to search
scientific article published on 27 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes. |
scientific article published on 27 March 2015 |
Statements
1 reference
A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes. (English)
1 reference
Hae Kyung Yang
Kyung Wan Min
Sung Woo Park
Kyong Soo Park
Ki-Ho Song
Doo-Man Kim
Moon-Kyu Lee
Yeon-Ah Sung
Sei Hyun Baik
In Joo Kim
Bong-Soo Cha
Jeong Hyun Park
Yu Bae Ahn
In-Kyu Lee
Soon Jib Yoo
Jaetaek Kim
Ie Byung Park
Tae Sun Park
27 March 2015
1 reference